CY1112336T1 - Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου) - Google Patents

Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου)

Info

Publication number
CY1112336T1
CY1112336T1 CY20111101004T CY111101004T CY1112336T1 CY 1112336 T1 CY1112336 T1 CY 1112336T1 CY 20111101004 T CY20111101004 T CY 20111101004T CY 111101004 T CY111101004 T CY 111101004T CY 1112336 T1 CY1112336 T1 CY 1112336T1
Authority
CY
Cyprus
Prior art keywords
medical use
trimethylsulfrazine
trimethylhydrazine
scleritis
medicament
Prior art date
Application number
CY20111101004T
Other languages
English (en)
Inventor
Ilmars Stonans
Eduard Tararak
Elena Andreyeva
Original Assignee
Grindeks, A Joint Stock Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40481525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1112336(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks, A Joint Stock Company filed Critical Grindeks, A Joint Stock Company
Publication of CY1112336T1 publication Critical patent/CY1112336T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Πρωτότυπη ιατρική χρήση αλάτων προπιονικού 3-(2,2,2-τριμεθυλυδραζινίου) για την παρασκευή ενός φαρμάκου για την πρόληψη και τη θεραπεία της σκληραθηρωμάτωσης.
CY20111101004T 2007-12-04 2011-10-25 Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου) CY1112336T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122272 2007-12-04
EP07122273 2007-12-04
EP08857026A EP2222293B1 (en) 2007-12-04 2008-12-03 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate

Publications (1)

Publication Number Publication Date
CY1112336T1 true CY1112336T1 (el) 2015-12-09

Family

ID=40481525

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101004T CY1112336T1 (el) 2007-12-04 2011-10-25 Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου)

Country Status (32)

Country Link
US (1) US20100234459A1 (el)
EP (1) EP2222293B1 (el)
JP (1) JP2011505408A (el)
KR (1) KR20100084688A (el)
CN (1) CN101951898B (el)
AR (1) AR069521A1 (el)
AT (1) ATE518536T1 (el)
AU (1) AU2008333262A1 (el)
BR (1) BRPI0819057A2 (el)
CA (1) CA2706354C (el)
CL (1) CL2008003551A1 (el)
CO (1) CO6280477A2 (el)
CY (1) CY1112336T1 (el)
DK (1) DK2222293T3 (el)
DO (1) DOP2010000163A (el)
EA (1) EA019424B1 (el)
GE (1) GEP20125673B (el)
HR (1) HRP20110744T1 (el)
IL (1) IL205961A0 (el)
MA (1) MA31993B1 (el)
MX (1) MX2010006255A (el)
MY (1) MY150508A (el)
PA (1) PA8805901A1 (el)
PE (1) PE20091037A1 (el)
PL (1) PL2222293T3 (el)
PT (1) PT2222293E (el)
RS (1) RS51992B (el)
SI (1) SI2222293T1 (el)
TN (1) TN2010000250A1 (el)
TW (1) TW200930356A (el)
WO (1) WO2009071585A1 (el)
ZA (1) ZA201003641B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2425835A1 (en) * 2010-08-18 2012-03-07 Grindeks, a joint stock company A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives
TWI487524B (zh) * 2010-12-03 2015-06-11 Tetra Sia 菸鹼酸和米曲肼之新穎治療組合

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667960B1 (en) * 2003-08-04 2008-02-13 "Joint Stock Company Grindeks" Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Also Published As

Publication number Publication date
EP2222293B1 (en) 2011-08-03
MA31993B1 (fr) 2011-01-03
BRPI0819057A2 (pt) 2015-05-05
US20100234459A1 (en) 2010-09-16
CO6280477A2 (es) 2011-05-20
TW200930356A (en) 2009-07-16
CA2706354A1 (en) 2009-06-11
SI2222293T1 (sl) 2011-12-30
CN101951898A (zh) 2011-01-19
WO2009071585A1 (en) 2009-06-11
ATE518536T1 (de) 2011-08-15
AR069521A1 (es) 2010-01-27
DOP2010000163A (es) 2010-08-31
PE20091037A1 (es) 2009-08-19
EA201000738A1 (ru) 2011-04-29
MX2010006255A (es) 2011-03-15
HRP20110744T1 (hr) 2011-11-30
EP2222293A1 (en) 2010-09-01
PA8805901A1 (es) 2009-07-23
EA019424B1 (ru) 2014-03-31
IL205961A0 (en) 2010-11-30
AU2008333262A1 (en) 2009-06-11
TN2010000250A1 (en) 2011-11-11
PT2222293E (pt) 2011-11-15
GEP20125673B (en) 2012-10-25
RS51992B (en) 2012-04-30
CN101951898B (zh) 2012-12-05
DK2222293T3 (da) 2011-11-21
MY150508A (en) 2014-01-30
JP2011505408A (ja) 2011-02-24
ZA201003641B (en) 2011-03-30
KR20100084688A (ko) 2010-07-27
PL2222293T3 (pl) 2012-01-31
CA2706354C (en) 2013-08-13
CL2008003551A1 (es) 2010-01-22

Similar Documents

Publication Publication Date Title
CY1122687T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1116927T1 (el) Προφαρμακα της τετραϋδροκανναβινολης, συνθεσεις οι οποιες περιλαμβανουν προφαρμακα της τετραϋδροκανναβινολης και μεθοδοι χρησης των ιδιων
CY1118232T1 (el) Διαμορφωτες φαρμακοκινητικων ιδιοτητων θεραπευτικων παραγοντων
CY1119488T1 (el) Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
ATE534378T1 (de) Titrierung von tapentadol
CY1120433T1 (el) Θεραπεια αγωνιστων μελατονινης
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
BRPI0816747A2 (pt) Dispositivo para o tratamento de um líquido medicinal, cassete medicinal, método para o acoplamento de um cassete e método para a verificação da impermeabilidade de um cassete medicinal
BRPI0718146A2 (pt) Dispositivos de infusão e métodos
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
CY1117568T1 (el) Χρηση μιας συνθεσης η οποια περιλαμβανει φορμοτερολη και διπροπιονικη βεκλομεθαζονη για την αγωγη μιας εξαρσης ασθματος
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
CY1110538T1 (el) S-μιρταζαπινη για τη θεραπεια των εξαψεων
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
CY1119315T1 (el) Στερεες μορφες που περιεχουν μελοξικαμη με βελτιωμενη στοματικη γευση και η διαδικασια για τηn προετοιμασια τους
CL2008003558A1 (es) Composicion farmaceutica que comprende valrubicina y sulfoxido de dimetilo en forma de dosis intravesical, util para tratar cancer a la vejiga.
CY1112336T1 (el) Ιατρικη χρηση του οξινου φουμαρικου και δισοξινου φωσφορικου προπιονικου 3-(2,2,2-τριμεθυλυδραζινιου)
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
CY1115587T1 (el) Μεθοδος και συνθεση για την θεραπεια παθησης με την μεσολαβηση ενος ληπτη σεροτονινης (sεrοτονιν)
NO20092496L (no) Ny terapeutisk anvendelse for behandling av leukemi
EA201000739A1 (ru) Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата
AR067351A1 (es) Combinacion de picotamida con nafronil